The app is now named MCI Triage Ready. Same app, same team, spacing corrected. This release is a full clinical-content audit of the protocol catalog and both triage trees. Twenty-one corrections, every one sourced to the current federal or CDC publication. TRIAGE - START and JumpSTART now separate "breathing spontaneously" from "breathing only after the airway is opened." A patient who breathes only after repositioning correctly terminates RED. Previously that patient could fall through to the respiratory-rate question and end up YELLOW. - START's respiratory criterion is now "greater than 30" alone. The "less than 10" lower bound is a 2021 National Field Triage Guideline criterion, not a START criterion, and has been removed from the prompt and both tag rules. - Added the SALT five-category GRAY (Expectant) tag with its definition, and a note that START and JumpSTART do not assign it. CHEMICAL - CANA is correctly identified as a DIAZEPAM 10 mg autoinjector, not midazolam, with CHEMM's adult and pediatric diazepam schedule. Midazolam is still shown as a defensible substitute. - DuoDote now carries its FDA weight limit: indicated above 41 kg (90 lb); not established at or below that weight. - Nebulized sodium bicarbonate corrected to 4.2%, so the label now matches the 1:1 dilution recipe beside it. - Phosgene observation extended to a minimum of 48 hours, with the 8-hour chest-film discharge criterion. BIOLOGICAL - Anthrax updated to CDC 2023: doxycycline and minocycline are the preferred protein-synthesis inhibitors when meningitis is possible, a 2-dose vaccine series, and obiltoxaximab or raxibacumab as preferred antitoxin. - Plague meningitis: chloramphenicol plus moxifloxacin or levofloxacin. Doxycycline is not a plague-meningitis agent. - Tularemia updated to CDC 2025: doxycycline moved to first-line, streptomycin reserved. - Corrected incubation and case-fatality figures for bubonic plague, smallpox, VEE, EEE and WEE. RADIOLOGICAL AND BLAST - Acute radiation syndrome subsyndrome thresholds corrected to CDC values; filgrastim dosing corrected to 10 mcg/kg/day. - Tympanic membrane rupture is no longer described as a screening sentinel. Isolated TM perforation is not a marker for occult primary blast injury, and a normal TM does not exclude it.

Updated reference doctrine and dosing guidance. All military citations updated from the superseded FM 4-02.285 to the three publications that replaced it: ATP 4-02.85 (chemical warfare agent casualties), ATP 4-02.84 (biological warfare agent casualties), and ATP 4-02.83 (nuclear and radiological casualties). Nerve agent: added dosing-scale guidance and an explicit distinction between nerve agent and organophosphate pesticide poisoning, which require very different amounts of atropine. Atropine titration endpoint clarified. DuoDote and ATNAA autoinjector content and repeat intervals stated directly. Radiological: expanded decorporation guidance, including Ca-DTPA to Zn-DTPA sequencing, agents for which chelation is not indicated, and the limits of DTPA. Updated About and disclaimer text to match the current cited sources.